Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Outcomes for patients with multiple myeloma (MM) have improved in recent years owing to use of novel agents and high-dose therapy followed by autologous stem cell transplant (ASCT). We analyzed the outcomes of 511 consecutive patients treated with novel therapies at our institution between 2006 and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia
Main Authors: Majithia, N, Rajkumar, SV, Lacy, MQ, Buadi, FK, Dispenzieri, A, Gertz, MA, Hayman, SR, Dingli, D, Kapoor, P, Hwa, L, Lust, JA, Russell, SJ, Go, RS, Kyle, RA, Kumar, SK
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541860/
https://ncbi.nlm.nih.gov/pubmed/27211270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.147
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados